Emergent Health (EMGE) Stock Price & Analysis

EMGE Stock Chart & Stats

$0.00$0.00(0.00%)

At close: Oct 12 11:11 AM EDT

Day’s Range: $0.01 - $0.01
52-Week Range: N/A
Previous Close: $0.01
Volume: N/A
Average Volume (3M): 5.06M
Market Cap: $42.70K
Enterprise Value: $2.46T
Total Cash (Recent Filing): $2,113
Total Debt (Recent Filing): $2.66M
Price to Earnings (P/E): ―
Beta: -235.14
Next Earnings: N/A
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

EMGE FAQ

What is Emergent Health’s market cap?

Emergent Health’s market cap is $42.70K.

When is Emergent Health’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Emergent Health’s earnings last quarter?

Emergent Health released its earnings results on Nov 21, 2022. The company reported -$0.003 earnings per share for the quarter.

Is Emergent Health overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Emergent Health pay dividends?

Emergent Health does not currently pay dividends.

What is Emergent Health’s EPS estimate?

Emergent Health’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Emergent Health have?

Emergent Health has 426,951,100 shares outstanding.

What happened to Emergent Health’s price movement after its last earnings report?

Emergent Health reported an EPS of -$0.003 in its last earnings report. Following the earnings report the stock price went same ―.

Which hedge fund is a major shareholder of Emergent Health?

Currently, no hedge funds are holding shares in EMGE

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Emergent Health

Emergent Health Corp. focuses on the creation and distribution of advanced regenerative medicine, alongside a variety of nutraceuticals and plant-derived nutritional supplements. The company's product portfolio features Vita-Stim, a potent nutrient formulated to strengthen the immune system, promote stem cell vitality, and support general well-being. Another key offering is Neuvitale, which not only assists in nourishing stem cells but also serves as a methyl donor to safeguard DNA integrity. For appetite regulation, they provide Hungarest, a dietary aid designed to manage hunger signals originating from both the brain and stomach. Additionally, EmergentO2 is available as a water oxygenator, aiming to elevate oxygen levels within the bloodstream. The firm also develops and markets several solutions for diminishing facial wrinkles. These products are distributed through a wide network of health food stores, pharmacies, and diverse other retail channels, reaching consumers throughout the United States and globally. Based in King of Prussia, Pennsylvania, Emergent Health Corp. transitioned to private ownership as of August 26, 2014.

Emergent Health (EMGE) Earnings & Revenues

Historic Earnings Reports

Similar Stocks

Stocks similar to EMGE
Company	Price & Change	Follow
SCNIScinai Immunotherapeutics
ADTXAditxt
NCELNewcelX
UPCUniverse Pharmaceuticals
VRAXVirax Biolabs Group Ltd. Class A

Compare EMGE Stocks >

Popular Stocks

Popular Stocks
Company	Price & Change	Follow
NVDANvidia
AAPLApple
MSFTMicrosoft